Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Chromocell Therapeutics Corporation | CHRO | AMEX | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
2,11 | 2,0001 | 2,125 | 2,01 | 2,11 |
Actualités Recentes
Date | Heure | Source | Titre |
---|---|---|---|
15/5/2024 | 22:15 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
15/5/2024 | 22:06 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13/5/2024 | 15:00 | GLOBE | Chromocell To Present at Alliance Global Partner’s.. |
09/4/2024 | 14:30 | GLOBE | Chromocell Issues Letter to Stockholders from Chief.. |
21/3/2024 | 13:30 | GLOBE | Chromocell Announces Formal Launch of Eye Pain Treatment.. |
18/3/2024 | 15:00 | GLOBE | Chromocell Names Frank Knuettel as Chief Executive Officer,.. |
11/3/2024 | 14:00 | GLOBE | Chromocell to Present at Sidoti Virtual Investor Conference.. |
27/2/2024 | 14:00 | GLOBE | Benuvia Operations, LLC and Chromocell Therapeutics Corp... |
21/2/2024 | 22:47 | GLOBE | Chromocell Therapeutics Announces Closing of Initial Public.. |
16/2/2024 | 14:00 | GLOBE | Chromocell Therapeutics Announces Pricing of Upsized $6.6.. |